Individuals with tumor driver genes have been gradually revealed in NSCLC patients, with notable examples such as the epidermal growth factor receptor (EGFR) and the anaplastic lymphoma kinase (ALK) [6]. This evidence concerns the gene ALK and non-small cell lung carcinoma.